Board of Directors
The PMC board of directors is dedicated to supporting the Coalition’s work to promote the understanding and adoption of personalized medicine concepts, services, and products.
![](https://www.personalizedmedicinecoalition.org/wp-content/uploads/2023/02/ala-export.jpg)
Antonio L. Andreu, M.D., Ph.D.
Scientific Director, EATRIS (European Infrastructure for Translational Medicine)
![](https://www.personalizedmedicinecoalition.org/wp-content/uploads/2024/06/c-schott.jpeg)
Cecilia Schott, Pharm.D.
Vice President, Head of Precision Medicine Portfolio Planning, GlaxoSmithKline
![](https://www.personalizedmedicinecoalition.org/wp-content/uploads/2023/02/amt-export.jpg)
Apostolia M. Tsimberidou, M.D., Ph.D.
Professor, Department of Investigational Therapeutics, The University of Texas MD Anderson Cancer Center
![](https://www.personalizedmedicinecoalition.org/wp-content/uploads/2023/02/jgw-export.jpg)
Jay G. Wohlgemuth, M.D.
Former Chief Medical Officer & Chief Scientific Officer, Quest Diagnostics; Managing Partner, Trusted Health Advisors